French genomics software firm SeqOne completed the acquisition of UK-based Congenica, gaining a CE-marked in vitro diagnostic clinical decision support platform and clinical interpretation services. These services address high demand in the US market to reduce diagnostic backlogs and provide signed reports for physicians. SeqOne recently launched a US subsidiary and signed initial clients, positioning itself as a leading independent genomics software provider and further consolidating clinical interpretation service offerings. Congenica’s prior expansion history and challenges led to this strategic alignment.